Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-04-08

AUTHORS

Harinder Gill, Chor-Sang Chim, Wing-Yan Au, Florence Loong, Eric Tse, Anskar Y. H. Leung, Yok-Lam Kwong

ABSTRACT

The optimal treatment strategy and outcome of non-gastric marginal zone lymphoma (MZL) remains undefined. The role of rituximab and fludarabine in MZL has not been critically appraised and compared with conventional chemotherapy. We retrospectively analyzed 81 consecutive patients with non-gastric MZL (mucosa-associated lymphoid tissue lymphoma, n = 66; splenic MZL, n = 11; nodal MZL, n = 4). As a group, the treatment results were favorable, with an overall response rate of 87% and a complete response (CR) rate of 73%. The CR rate was similar for conventional chemotherapy, and rituximab- and fludarabine-containing regimens. However, the relapse rate was significantly decreased in rituximab- and fludarabine-containing regimens. The use of rituximab and fludarabine was associated with acceptable side effects. For splenic MZL, splenectomy was significantly associated with a superior CR rate. Early stage, good performance status, and low international prognostic index risk scores significantly impacted on CR rate and survivals. Rituximab and fludarabine were safe for non-gastric MZL and resulted in more durable remissions. More... »

PAGES

1399-1407

References to SciGraph publications

  • 2007-04. Splenic marginal zone lymphoma with and without villous lymphocytes in CURRENT TREATMENT OPTIONS IN ONCOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00277-011-1226-z

    DOI

    http://dx.doi.org/10.1007/s00277-011-1226-z

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1035541859

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/21476016


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adolescent", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged, 80 and over", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lymphoma, B-Cell, Marginal Zone", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Retrospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Young Adult", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
              "id": "http://www.grid.ac/institutes/grid.415550.0", 
              "name": [
                "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gill", 
            "givenName": "Harinder", 
            "id": "sg:person.01171470630.09", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171470630.09"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
              "id": "http://www.grid.ac/institutes/grid.415550.0", 
              "name": [
                "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chim", 
            "givenName": "Chor-Sang", 
            "id": "sg:person.0722115232.29", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722115232.29"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
              "id": "http://www.grid.ac/institutes/grid.415550.0", 
              "name": [
                "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Au", 
            "givenName": "Wing-Yan", 
            "id": "sg:person.010503716312.88", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010503716312.88"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, Queen Mary Hospital, Hong Kong, China", 
              "id": "http://www.grid.ac/institutes/grid.415550.0", 
              "name": [
                "Department of Pathology, Queen Mary Hospital, Hong Kong, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Loong", 
            "givenName": "Florence", 
            "id": "sg:person.0676541530.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676541530.05"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
              "id": "http://www.grid.ac/institutes/grid.415550.0", 
              "name": [
                "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tse", 
            "givenName": "Eric", 
            "id": "sg:person.01126550300.26", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126550300.26"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
              "id": "http://www.grid.ac/institutes/grid.415550.0", 
              "name": [
                "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Leung", 
            "givenName": "Anskar Y. H.", 
            "id": "sg:person.011121156664.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011121156664.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China", 
              "id": "http://www.grid.ac/institutes/grid.415550.0", 
              "name": [
                "Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kwong", 
            "givenName": "Yok-Lam", 
            "id": "sg:person.01100514066.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100514066.14"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s11864-007-0026-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029397952", 
              "https://doi.org/10.1007/s11864-007-0026-0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2011-04-08", 
        "datePublishedReg": "2011-04-08", 
        "description": "The optimal treatment strategy and outcome of non-gastric marginal zone lymphoma (MZL) remains undefined. The role of rituximab and fludarabine in MZL has not been critically appraised and compared with conventional chemotherapy. We retrospectively analyzed 81 consecutive patients with non-gastric MZL (mucosa-associated lymphoid tissue lymphoma, n\u2009=\u200966; splenic MZL, n\u2009=\u200911; nodal MZL, n\u2009=\u20094). As a group, the treatment results were favorable, with an overall response rate of 87% and a complete response (CR) rate of 73%. The CR rate was similar for conventional chemotherapy, and rituximab- and fludarabine-containing regimens. However, the relapse rate was significantly decreased in rituximab- and fludarabine-containing regimens. The use of rituximab and fludarabine was associated with acceptable side effects. For splenic MZL, splenectomy was significantly associated with a superior CR rate. Early stage, good performance status, and low international prognostic index risk scores significantly impacted on CR rate and survivals. Rituximab and fludarabine were safe for non-gastric MZL and resulted in more durable remissions.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00277-011-1226-z", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1358129", 
            "issn": [
              "0939-5555", 
              "1432-0584"
            ], 
            "name": "Annals of Hematology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "12", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "90"
          }
        ], 
        "keywords": [
          "marginal zone lymphoma", 
          "CR rate", 
          "conventional chemotherapy", 
          "response rate", 
          "treatment results", 
          "superior CR rates", 
          "good performance status", 
          "complete response rate", 
          "acceptable side effects", 
          "splenic marginal zone lymphoma", 
          "optimal treatment strategy", 
          "overall response rate", 
          "durable remissions", 
          "performance status", 
          "consecutive patients", 
          "relapse rate", 
          "clinicopathologic features", 
          "treatment strategies", 
          "risk score", 
          "side effects", 
          "rituximab", 
          "regimens", 
          "fludarabine", 
          "chemotherapy", 
          "early stages", 
          "remission", 
          "splenectomy", 
          "patients", 
          "lymphoma", 
          "rate", 
          "survival", 
          "outcomes", 
          "scores", 
          "status", 
          "group", 
          "role", 
          "effect", 
          "results", 
          "use", 
          "stage", 
          "strategies", 
          "features"
        ], 
        "name": "Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results", 
        "pagination": "1399-1407", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1035541859"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00277-011-1226-z"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "21476016"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00277-011-1226-z", 
          "https://app.dimensions.ai/details/publication/pub.1035541859"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:54", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_540.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00277-011-1226-z"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00277-011-1226-z'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00277-011-1226-z'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00277-011-1226-z'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00277-011-1226-z'


     

    This table displays all metadata directly associated to this object as RDF triples.

    195 TRIPLES      21 PREDICATES      79 URIs      70 LITERALS      18 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00277-011-1226-z schema:about N028d97f9ffd142c1a097e2c9defe4ce6
    2 N2c4e2fa9e81048aa9c77a76709feb359
    3 N59ce186871fd48a98b2d73306f6c9347
    4 Na865c5e55e8d4c7b82b6cb4f6f40a02a
    5 Naa366d35de2d47c3817d716e0426c441
    6 Nbf9c61fd02e14c0c83a80005489f3016
    7 Nc3190e6ae66d43bc9fb67179e3c2e406
    8 Ncabc1817e20144bc89e781b7b1d88537
    9 Nd35f941e6c86468c9c7b1d5fa5ae7c69
    10 Nda30ec0ad447429e83e3c37725e2c77e
    11 Ne970adafbd424b82972eab4cd85c16c0
    12 anzsrc-for:11
    13 anzsrc-for:1112
    14 schema:author N41d6e8adf470454db7ca98c6e8547ef1
    15 schema:citation sg:pub.10.1007/s11864-007-0026-0
    16 schema:datePublished 2011-04-08
    17 schema:datePublishedReg 2011-04-08
    18 schema:description The optimal treatment strategy and outcome of non-gastric marginal zone lymphoma (MZL) remains undefined. The role of rituximab and fludarabine in MZL has not been critically appraised and compared with conventional chemotherapy. We retrospectively analyzed 81 consecutive patients with non-gastric MZL (mucosa-associated lymphoid tissue lymphoma, n = 66; splenic MZL, n = 11; nodal MZL, n = 4). As a group, the treatment results were favorable, with an overall response rate of 87% and a complete response (CR) rate of 73%. The CR rate was similar for conventional chemotherapy, and rituximab- and fludarabine-containing regimens. However, the relapse rate was significantly decreased in rituximab- and fludarabine-containing regimens. The use of rituximab and fludarabine was associated with acceptable side effects. For splenic MZL, splenectomy was significantly associated with a superior CR rate. Early stage, good performance status, and low international prognostic index risk scores significantly impacted on CR rate and survivals. Rituximab and fludarabine were safe for non-gastric MZL and resulted in more durable remissions.
    19 schema:genre article
    20 schema:isAccessibleForFree true
    21 schema:isPartOf N2b28a2b18e8e49e08d62701cd4f3bd6e
    22 Nd72b0a85587f4429a0937b2182115b52
    23 sg:journal.1358129
    24 schema:keywords CR rate
    25 acceptable side effects
    26 chemotherapy
    27 clinicopathologic features
    28 complete response rate
    29 consecutive patients
    30 conventional chemotherapy
    31 durable remissions
    32 early stages
    33 effect
    34 features
    35 fludarabine
    36 good performance status
    37 group
    38 lymphoma
    39 marginal zone lymphoma
    40 optimal treatment strategy
    41 outcomes
    42 overall response rate
    43 patients
    44 performance status
    45 rate
    46 regimens
    47 relapse rate
    48 remission
    49 response rate
    50 results
    51 risk score
    52 rituximab
    53 role
    54 scores
    55 side effects
    56 splenectomy
    57 splenic marginal zone lymphoma
    58 stage
    59 status
    60 strategies
    61 superior CR rates
    62 survival
    63 treatment results
    64 treatment strategies
    65 use
    66 schema:name Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results
    67 schema:pagination 1399-1407
    68 schema:productId N531433a2700046bfacfd0a53deca81b7
    69 Nf50929ce04014437bf42998ecce379be
    70 Nfee45fb253014562be13a15c20ea2e12
    71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035541859
    72 https://doi.org/10.1007/s00277-011-1226-z
    73 schema:sdDatePublished 2022-11-24T20:54
    74 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    75 schema:sdPublisher N0ec8ed7f0d164f228092eb88d70bac16
    76 schema:url https://doi.org/10.1007/s00277-011-1226-z
    77 sgo:license sg:explorer/license/
    78 sgo:sdDataset articles
    79 rdf:type schema:ScholarlyArticle
    80 N00192547ab2f4fea8c68f9fdaee233ea rdf:first sg:person.0722115232.29
    81 rdf:rest N209d751b67f745e58a5490775a73f0b1
    82 N028d97f9ffd142c1a097e2c9defe4ce6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    83 schema:name Aged, 80 and over
    84 rdf:type schema:DefinedTerm
    85 N0ec8ed7f0d164f228092eb88d70bac16 schema:name Springer Nature - SN SciGraph project
    86 rdf:type schema:Organization
    87 N1991766c90dd42a5997215527d7561ab rdf:first sg:person.01100514066.14
    88 rdf:rest rdf:nil
    89 N209d751b67f745e58a5490775a73f0b1 rdf:first sg:person.010503716312.88
    90 rdf:rest Nb42e3fbb2d9040d7959a30b7c6e3c067
    91 N2b28a2b18e8e49e08d62701cd4f3bd6e schema:volumeNumber 90
    92 rdf:type schema:PublicationVolume
    93 N2c4e2fa9e81048aa9c77a76709feb359 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    94 schema:name Adolescent
    95 rdf:type schema:DefinedTerm
    96 N41d6e8adf470454db7ca98c6e8547ef1 rdf:first sg:person.01171470630.09
    97 rdf:rest N00192547ab2f4fea8c68f9fdaee233ea
    98 N531433a2700046bfacfd0a53deca81b7 schema:name doi
    99 schema:value 10.1007/s00277-011-1226-z
    100 rdf:type schema:PropertyValue
    101 N59ce186871fd48a98b2d73306f6c9347 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    102 schema:name Female
    103 rdf:type schema:DefinedTerm
    104 N8b9742d59f0d42199f0b824bf8aae58f rdf:first sg:person.01126550300.26
    105 rdf:rest Nea93f04551bf4393aa9025667c795a26
    106 Na865c5e55e8d4c7b82b6cb4f6f40a02a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    107 schema:name Retrospective Studies
    108 rdf:type schema:DefinedTerm
    109 Naa366d35de2d47c3817d716e0426c441 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Humans
    111 rdf:type schema:DefinedTerm
    112 Nb42e3fbb2d9040d7959a30b7c6e3c067 rdf:first sg:person.0676541530.05
    113 rdf:rest N8b9742d59f0d42199f0b824bf8aae58f
    114 Nbf9c61fd02e14c0c83a80005489f3016 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Adult
    116 rdf:type schema:DefinedTerm
    117 Nc3190e6ae66d43bc9fb67179e3c2e406 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    118 schema:name Young Adult
    119 rdf:type schema:DefinedTerm
    120 Ncabc1817e20144bc89e781b7b1d88537 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    121 schema:name Lymphoma, B-Cell, Marginal Zone
    122 rdf:type schema:DefinedTerm
    123 Nd35f941e6c86468c9c7b1d5fa5ae7c69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Male
    125 rdf:type schema:DefinedTerm
    126 Nd72b0a85587f4429a0937b2182115b52 schema:issueNumber 12
    127 rdf:type schema:PublicationIssue
    128 Nda30ec0ad447429e83e3c37725e2c77e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Aged
    130 rdf:type schema:DefinedTerm
    131 Ne970adafbd424b82972eab4cd85c16c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Middle Aged
    133 rdf:type schema:DefinedTerm
    134 Nea93f04551bf4393aa9025667c795a26 rdf:first sg:person.011121156664.42
    135 rdf:rest N1991766c90dd42a5997215527d7561ab
    136 Nf50929ce04014437bf42998ecce379be schema:name pubmed_id
    137 schema:value 21476016
    138 rdf:type schema:PropertyValue
    139 Nfee45fb253014562be13a15c20ea2e12 schema:name dimensions_id
    140 schema:value pub.1035541859
    141 rdf:type schema:PropertyValue
    142 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    143 schema:name Medical and Health Sciences
    144 rdf:type schema:DefinedTerm
    145 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    146 schema:name Oncology and Carcinogenesis
    147 rdf:type schema:DefinedTerm
    148 sg:journal.1358129 schema:issn 0939-5555
    149 1432-0584
    150 schema:name Annals of Hematology
    151 schema:publisher Springer Nature
    152 rdf:type schema:Periodical
    153 sg:person.010503716312.88 schema:affiliation grid-institutes:grid.415550.0
    154 schema:familyName Au
    155 schema:givenName Wing-Yan
    156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010503716312.88
    157 rdf:type schema:Person
    158 sg:person.01100514066.14 schema:affiliation grid-institutes:grid.415550.0
    159 schema:familyName Kwong
    160 schema:givenName Yok-Lam
    161 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100514066.14
    162 rdf:type schema:Person
    163 sg:person.011121156664.42 schema:affiliation grid-institutes:grid.415550.0
    164 schema:familyName Leung
    165 schema:givenName Anskar Y. H.
    166 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011121156664.42
    167 rdf:type schema:Person
    168 sg:person.01126550300.26 schema:affiliation grid-institutes:grid.415550.0
    169 schema:familyName Tse
    170 schema:givenName Eric
    171 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126550300.26
    172 rdf:type schema:Person
    173 sg:person.01171470630.09 schema:affiliation grid-institutes:grid.415550.0
    174 schema:familyName Gill
    175 schema:givenName Harinder
    176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171470630.09
    177 rdf:type schema:Person
    178 sg:person.0676541530.05 schema:affiliation grid-institutes:grid.415550.0
    179 schema:familyName Loong
    180 schema:givenName Florence
    181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676541530.05
    182 rdf:type schema:Person
    183 sg:person.0722115232.29 schema:affiliation grid-institutes:grid.415550.0
    184 schema:familyName Chim
    185 schema:givenName Chor-Sang
    186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722115232.29
    187 rdf:type schema:Person
    188 sg:pub.10.1007/s11864-007-0026-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029397952
    189 https://doi.org/10.1007/s11864-007-0026-0
    190 rdf:type schema:CreativeWork
    191 grid-institutes:grid.415550.0 schema:alternateName Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China
    192 Department of Pathology, Queen Mary Hospital, Hong Kong, China
    193 schema:name Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China
    194 Department of Pathology, Queen Mary Hospital, Hong Kong, China
    195 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...